Furthermore, TLR9 overexpression in triple-negative breast cancer leads to epithelial-to-mesenchymal transition (EMT) induction and EGFR pathway deregulation, suggesting a role in the carcinogenesis of this tumor subtype [41]. This evidence concerns the gene EGFR and triple-negative breast carcinoma.